This inventor holds 1 USPTO granted patent and 48 published patent applications and 1 EPO patent. Top assignee: Targazyme, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Thomas E Ichim: Innovator in Cell Therapy
Introduction
Thomas E Ichim is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cell therapy, particularly through his innovative approaches to augmenting the efficacy of such treatments. His work is characterized by a focus on enhancing cellular properties to improve therapeutic outcomes.
Latest Patents
Ichim holds a patent titled "Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase." This patent discloses methods, compositions of matter, and kits that are useful for augmenting cells through the modification of cellular membrane properties following ex vivo treatment. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Ichim is associated with Targazyme, Inc., a company dedicated to developing innovative therapies. His role at Targazyme has allowed him to work on cutting-edge research that aims to improve the effectiveness of cell therapies. His expertise in this area has positioned him as a key figure in the field.
Collaborations
Ichim collaborates with Leonard Miller, a fellow professional in the industry. Their partnership reflects a shared commitment to advancing cell therapy and improving patient outcomes through innovative research.
Conclusion
Thomas E Ichim is a notable inventor whose work in cell therapy has the potential to transform treatment methodologies. His innovative patent and collaboration with industry professionals highlight his dedication to enhancing therapeutic efficacy.